- 2025-09-26 10:59Vidutolimod (CMP-001) 147063-80-7
- 2025-09-26 10:59EGFR-IN-61 2890261-81-9
- 2025-09-26 10:59R8-T198wt 2305815-72-7
- 2025-09-26 10:59ML115 912798-42-6
- 2025-09-26 10:59UM-3006 1927013-87-3
- 2025-09-26 10:59EGFR-IN-5 2225887-26-1
- 2025-09-26 10:59PIM447 dihydrochloride 1820565-69-2
- 2025-09-26 10:59Tri(TLR4-IN-C34-PEG2-amide-PEG1)-amide-C3-COOH
- 2025-09-26 10:59inS3-54-A18 328998-53-4
- 2025-09-26 10:59EGFR-IN-48 2882851-77-4
- 2025-09-26 10:59Pim1/AKK1-IN-1 1093222-27-5
- 2025-09-26 10:59Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH
- 2025-09-26 10:59HP590 2971855-37-3
- 2025-09-26 10:59EGFR-IN-45 2765560-03-8
- 2025-09-26 10:59PIM1-IN-4 2762767-48-4
- 2025-09-26 10:59Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH
- 2025-09-26 10:59EGFR-IN-24 2757548-54-0
- 2025-09-26 10:59GYY 4137 morpholine salt 106740-09-4
- 2025-09-26 10:59TMX-201 1149339-78-5
- 2025-09-26 10:59EGFR-IN-22 2634646-14-1
